Blood mRNA expression of REV3L and TYMS as potential predictive biomarkers from platinum-based chemotherapy plus pemetrexed in non-small cell lung cancer patients
2019; Springer Science+Business Media; Volume: 85; Issue: 3 Linguagem: Inglês
10.1007/s00280-019-04008-9
ISSN1432-0843
AutoresM. Teresa Agulló-Ortuño, Inmaculada García‐Ruíz, C. Vanesa Díaz-García, Ana B. Enguita, Virginia Pardo, Elena Prieto‐García, Santiago Ponce, L. Iglesias, Jon Zugazagoitia, José A. López-Martín, Luis Paz‐Ares, Juan Antonio Vargas,
Tópico(s)Ferroptosis and cancer prognosis
Referência(s)